PSS---2Q Operating Profit Turns to Black with 0.84 Billion Yen
For the second quarter of the fiscal year ending June 2026, consolidated performance showed a 15.3% year-on-year increase in net sales to JPY 25.34 billion, with operating profit reaching JPY 84 million (compared to an operating loss of JPY 1.11 billion in the same period last year). Devices for genetic testing that utilize nucleic acid extraction reagents, branded as the 'PSS Platform,' performed steadily. Sales of nucleic acid extraction reagents and related consumables used in these devices also increased.
Fisco JapanFeb 17 07:38